Science Explorer Back to mapMap

Most cited papers from Michigan Cancer Research Consortium

What are the most cited papers from Michigan Cancer Research Consortium?

The most cited paper from Michigan Cancer Research Consortium is "Comprehensive molecular characterization of gastric adenocarcinoma" (Adam Joel Bass et al., 2014), with 6,680 citations. Next come "Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study" (2,047) and "Amplification of a gene encoding a p53-associated protein in human sarcomas" (1,969).

Showing 50 of 60 papers. Every paper with more than 122 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Comprehensive molecular characterization of gastric adenocarcinoma Adam Joel Bass et al. · Nature Open access258 authors 23 Jul 2014 6,680
2 Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study Jeffrey D. Bradley et al. · The Lancet Oncology Open access 15 Jan 2015 2,047
3 Amplification of a gene encoding a p53-associated protein in human sarcomas Jonathan D. Oliner, Kenneth W. Kinzler, Paul S. Meltzer et al. · Nature Jul 1992 1,969
4 Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11 Xueting Lang et al. · Cancer Discovery Open access 25 Sep 2019 1,094
5 Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) Andrea Cossarizza et al. · European Journal of Immunology Open access436 authors Oct 2019 1,014
6 Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial Brian G.M. Durie, Antje Hoering, Muneer Hyder Abidi et al. · The Lancet Open access 23 Dec 2016 911
7 Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma Sapna Pradyuman Patel et al. · New England Journal of Medicine Open access Mar 2023 893
8 Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer Ramez Nassef Eskander et al. · New England Journal of Medicine Open access 27 Mar 2023 761
9 CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts Christophe Ginestier, Suling Liu, Mark E. Diebel et al. · Journal of Clinical Investigation Open access 7 Jan 2010 751
10 Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers Sophie Rousseaux, Alexandra Debernardi, Baptiste Jacquiau et al. · Science Translational Medicine Open access 22 May 2013 635
11 Quantifying changes in the thiol redox proteome upon oxidative stress in vivo Lars Ingo Ole Leichert, Florian Gehrke, Harini V. Gudiseva et al. · Proceedings of the National Academy of Sciences Open access 14 Feb 2008 534
12 Acute graft-versus-host disease does not require alloantigen expression on host epithelium Takanori Teshima, Rainer Ordemann, Pavan R. Reddy et al. · Nature Medicine Jun 2002 522
13 A Functional Role for Nlrp6 in Intestinal Inflammation and Tumorigenesis Grace Chen, Maochang Liu, Fuyuan Wang et al. · The Journal of Immunology Open access 5 May 2011 439
14 Jasmonate-inducible plant enzymes degrade essential amino acids in the herbivore midgut Hui Chen, Curtis Gene Wilkerson, Jason A. Kuchar et al. · Proceedings of the National Academy of Sciences Open access 15 Dec 2005 361
15 Heterogeneity and plasticity in the development of language: a 17‐year follow‐up of children referred early for possible autism Andrew R. Pickles, Deborah K. Anderson, Catherine Lord · Journal of Child Psychology and Psychiatry Open access 30 May 2014 341
16 SAR405838: An Optimized Inhibitor of MDM2–p53 Interaction That Induces Complete and Durable Tumor Regression Shaomeng Wang et al. · Cancer Research Open access 22 Aug 2014 339
17 The dog as a cancer model Chand Khanna, Kerstin Lindblad‐Toh, David M. Vail et al. · Nature Biotechnology Sep 2006 338
18 A self-reinforced cementitious composite for building-scale 3D printing Daniel G. Soltan, Victor C. Li · Cement and Concrete Composites 20 Mar 2018 330
19 Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2 D. L. Barton, H. Liu, S. R. Dakhil et al. · JNCI Journal of the National Cancer Institute Open access 13 Jul 2013 298
20 Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment Kevin M. Tharp, Kelly Kersten, Ori Maller et al. · Nature Cancer Open access 3 Jun 2024 290
21 Psychosocial service use and unmet need among recently diagnosed adolescent and young adult cancer patients Brad Zebrack, Rebecca G. Block, Brandon Hayes‐Lattin et al. · Cancer Open access 28 Jun 2012 279
22 Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT) Brian G.M. Durie, Antje Hoering, Rachael Sexton et al. · Blood Cancer Journal Open access 11 May 2020 256
23 Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance) Charles L. Loprinzi, Rui Qin, Shaker R. Dakhil et al. · Journal of Clinical Oncology Open access 3 Dec 2013 243
24 Host Dendritic Cells Alone Are Sufficient to Initiate Acute Graft-versus-Host Disease Ulrich A. Duffner, Yoshinobu Maeda, Kenneth R. Cooke et al. · The Journal of Immunology Jun 2004 243
25 Immunobiology of acute graft-versus-host disease Pavan R. Reddy, James L.M. Ferrara · Blood Reviews 23 Apr 2003 241
26 Age-Associated Mitochondrial Dysfunction Accelerates Atherogenesis Daniel J. Tyrrell, Muriel G. Blin, Jianrui Song et al. · Circulation Research Open access 9 Dec 2019 237
27 Two nearly identical terpene synthases catalyze the formation of nerolidol and linalool in snapdragon flowers Dinesh A. Nagegowda, Michael Gutensohn, Curtis Gene Wilkerson et al. · The Plant Journal 20 Mar 2008 237
28 Matrix Metalloproteinases (MMPs) Regulate Fibrin-invasive Activity via MT1-MMP–dependent and –independent Processes Kevin B. Hotary, Ikuo Yana, Farideh Sabeh et al. · The Journal of Experimental Medicine Open access 28 Jan 2002 220
29 Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA Debra L. Barton, Gamini S. Soori, Brent A. Bauer et al. · Supportive Care in Cancer Open access 5 May 2009 216
30 GM-CSF Mediates Mesenchymal–Epithelial Cross-talk in Pancreatic Cancer Meghna Waghray, Malica Yalamanchili, Michele L. Dziubinski et al. · Cancer Discovery Open access 16 May 2016 213
31 Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB–Mediated Production of CXCL1 Samantha B. Kemp, Eileen S. Carpenter, Nina G. Steele et al. · Cancer Research Open access 28 May 2021 212
32 Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery Wendy Demark‐Wahnefried, Thomas J. Polascik, Stephen L. George et al. · Cancer Epidemiology Biomarkers & Prevention Open access Dec 2008 210
33 Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer Longchuan Bai et al. · Cancer Research Open access 16 Feb 2017 200
34 Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238 James Larkin et al. · Clinical Cancer Research Open access 14 Apr 2023 194
35 Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma Trisha M. Wise-Draper et al. · Clinical Cancer Research Open access 28 Feb 2022 192
36 Quality of Life Analysis of a Radiation Dose–Escalation Study of Patients With Non–Small-Cell Lung Cancer Benjamin Movsas, Chen Hu, Jeffrey A. Sloan et al. · JAMA Oncology Open access 25 Nov 2015 183
37 Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial Ari M. Vanderwalde et al. · Nature Medicine Open access 17 Aug 2023 180
38 The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial Lisa A. Kottschade, Jeff A. Sloan, Miroslaw A. Mazurczak et al. · Supportive Care in Cancer Open access 9 Oct 2010 173
39 Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes, N07C1 Charles L. Loprinzi, Rui Qin, Ernie P. Baclueva et al. · Journal of Clinical Oncology Open access 9 Nov 2009 164
40 RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer Yajing Liu, Monika Leigh Burness, Rachel Martin-Trevino et al. · Clinical Cancer Research 29 Dec 2016 163
41 Cannabis smoking and lung cancer risk: Pooled analysis in the I nternational L ung C ancer C onsortium Li Rita Zhang, Hal Morgenstern, Sander Greenland et al. · International Journal of Cancer Open access 20 Jun 2014 162
42 A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors David C. Smith, Peter D. Eisenberg, Georgy Moiseevich Manikhas et al. · Clinical Cancer Research 17 Oct 2014 161
43 Targeting E3 Ubiquitin Ligases for Cancer Therapy Yi Sun · Cancer Biology & Therapy Nov 2003 155
44 Stability of Plant Defense Proteins in the Gut of Insect Herbivores Hui Chen, Eliana Gonzales‐Vigil, Curtis Gene Wilkerson et al. · PLANT PHYSIOLOGY Open access 9 Feb 2007 154
45 A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913 Prakash Chinnaiyan, Minhee Won, Patrick Yung Wen et al. · Neuro-Oncology Open access 30 Oct 2017 153
46 Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine Yee Sun Tan, Kanokwan Sansanaphongpricha, Yuying Xie et al. · Clinical Cancer Research Open access 16 May 2018 152
47 Systemic Delivery of an Adjuvant CXCR4–CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy Mahmoud S. Alghamri et al. · ACS Nano Open access 26 May 2022 149
48 Youth Empowerment Solutions for Peaceful Communities: Combining Theory and Practice in a Community-Level Violence Prevention Curriculum Marc A. Zimmerman, Sarah E. Stewart, Susan Morrel‐Samuels et al. · Health Promotion Practice 8 Nov 2010 148
49 Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617 Jian‐Yue Jin, Chen Hu, Ying Xiao et al. · Cancers Open access 8 Dec 2021 144
50 Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and Degradation Wan Du et al. · Cancer Discovery Open access 24 Feb 2021 141

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.